Stillbirth

Healthy Blue Kansas Marks Mother’s Day by Partnering with Count the Kicks to Improve Birth Outcomes and Save Lives Across Kansas

Retrieved on: 
Mercoledì, Maggio 8, 2024
Mobile, Wireless, Technology, Training, Health Technology, Other Philanthropy, Health Insurance, Hospitals, Baby, Maternity, Other Education, Insurance, Education, Women, Professional Services, Health, Philanthropy, Practice Management, Apps, Applications, General Health, Foundation, Family, Consumer, Software, Internet, Other Health, Pain, Investment, Stillbirth, Pregnancy, Woman, Hospital, Research, Parent, Kick, Movement, Face, Alaska Natives, Death, Birth control

In commemoration of this year’s Mother’s Day holiday, Healthy Blue Kansas is partnering with Healthy Birth Day, Inc. to raise awareness about resources that can improve birth outcomes for Kansas families.

Key Points: 
  • In commemoration of this year’s Mother’s Day holiday, Healthy Blue Kansas is partnering with Healthy Birth Day, Inc. to raise awareness about resources that can improve birth outcomes for Kansas families.
  • Healthy Blue Kansas has made investments to make Healthy Birth Day’s Count the Kicks stillbirth prevention program and resources available to expecting families across the entire state at no charge.
  • This method has been proven to improve birth outcomes for moms and babies, and save lives.
  • “That’s why Healthy Blue Kansas is proud of this initiative to bring the innovative solutions of Count the Kicks to our state.

Komodo Health & Partners Present 33 Real-World Evidence Research Studies at ISPOR 2024

Retrieved on: 
Lunedì, Maggio 6, 2024
Technology, Health, Venture Capital, Professional Services, Artificial Intelligence, Oncology, Other Science, Mental Health, Research, Software, Health Technology, Science, COVID-19, Clinical Trials, Komodo, University of Washington, Lennox–Gastaut syndrome, FDA, Public, University, Target, International Society, RWE, Pregnancy, Policy, AI, Prevalence, Colorectal cancer, Myriad Genetics, LGS, Chronic inflammatory demyelinating polyneuropathy, Neutropenia, CRC, Conference, Workflow, REMS, Genetics, Schizophrenia, Takeda Pharmaceutical Company, Mental health, Neurology, RWD, MPH, Patient, Hypertension, Epilepsy, Gestational age, Standard of care, Stillbirth, Pharmacoeconomics, ZS, Merck, ZS Associates, Breast cancer, Mitigation, Pharmaceutical industry

Komodo Health today announced the publication of 33 new health economics and outcomes research (HEOR) studies using its Healthcare Map and AI-powered technology platform.

Key Points: 
  • Komodo Health today announced the publication of 33 new health economics and outcomes research (HEOR) studies using its Healthcare Map and AI-powered technology platform.
  • The studies, to be featured at the 2024 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Global Conference, shed light on important disease trends spanning women’s health, oncology, mental health, hypertension, neurology, and more.
  • Komodo Health researchers studied the differences in patient outcomes for pregnant women who continued or discontinued the use of antidepressants during pregnancy.
  • Komodo Health researchers analyzed whether the COVID-19 pandemic exacerbated inequities in breast cancer care through its impact on breast cancer staging and HCRU.

Butterfly Network, Clinton Health Access Initiative, and Global Ultrasound Institute Partner to Advance Maternal and Fetal Health in South Africa

Retrieved on: 
Lunedì, Aprile 15, 2024
Technology, Medical Devices, Semiconductor, Hospitals, Health Technology, Software, Training, General Health, Health, Education, Melon, Mortality, Organization, Public sector, Patient, GUSI, Health equity, Pregnancy, Woman, Core Group, Health care, Partnership, Entrepreneurship, Disease, CHAI, Clinton Foundation, Global Health, Bill, Mother, Multimedia, JAMF, Stillbirth, Butterfly network, Network, Global health, Nursing

As of today, the organizations have initiated Phase Two of Butterfly's 1,000 iQ+ probe deployment and point-of-care ultrasound training program for maternal and fetal health in Sub-Saharan Africa.

Key Points: 
  • As of today, the organizations have initiated Phase Two of Butterfly's 1,000 iQ+ probe deployment and point-of-care ultrasound training program for maternal and fetal health in Sub-Saharan Africa.
  • View the full release here: https://www.businesswire.com/news/home/20240415955318/en/
    Healthcare workers in Eastern Cape, South Africa enrolled in a week-long Butterfly point-of-care ultrasound training program.
  • "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa.
  • We look forward to working closely with Butterfly Network and the Global Ultrasound Institute to achieve our shared goal of advancing global health equity."

Canada’s inaction in Gaza marks a failure of its feminist foreign policy

Retrieved on: 
Mercoledì, Marzo 13, 2024
Malnutrition, Woman, Violence, Hamas, Failure, Poverty, RCMP, Pregnancy, Feminism, Sale, FIAP, Empowerment, Maternal death, Rape, Food, Risk, Safety, Health, Global Affairs Canada, United Nations, Stillbirth, Foreign Affairs, Non-governmental organization, Infant, Mother, Policy, Miscarriage, UN, Reproductive rights, Joly, Water, Face, Birth control

“Peace and prosperity are every person’s birthright.” So opened then Minister of Foreign Affairs Chrystia Freeland’s introduction to Canada’s Feminist International Assistance Policy (FIAP).

Key Points: 
  • “Peace and prosperity are every person’s birthright.” So opened then Minister of Foreign Affairs Chrystia Freeland’s introduction to Canada’s Feminist International Assistance Policy (FIAP).
  • Launched in 2017, the policy stated that Canada would take an explicitly feminist approach to international assistance, including a commitment to protecting women’s sexual and reproductive rights.
  • Many considered it to be a forward-thinking policy that builds on the past work of NGOs and other international partners.
  • In addition to funding, Joly also offered RCMP support to help investigate the crimes of sexual violence against Israeli women.

Palestinian women’s rights long ignored

  • Her statement came after United Nations experts expressed alarm over “credible allegations of egregious human rights violations to which Palestinian women and girls continue to be subjected in the Gaza Strip and the West Bank.” They cited reports of arbitrary executions, killings, detentions and sexual abuse of Palestinian women and girls by Israeli forces.
  • Even before the current escalation of violence, Canada’s support of Israel’s actions have long been identified as a significant limitation of FIAP.
  • Palestinian women also face increased risk of sexual violence.
  • There are credible reports of sexual violence being used as a tool of war against both Israeli and Palestinian women.

Reproductive health in Gaza in a dire state

  • An estimated 50,000 pregnant women in Gaza are at increased risk of miscarriage, stillbirth and maternal death.
  • The widespread food crisis has also had dire implications for reproductive and maternal health.
  • Malnutrition affects maternal health, and can also have long-term consequences for the health of mothers and their children.

Canada must act

  • Meanwhile, Canadian exports of military equipment to Israel have not only continued, but have increased since October.
  • Global Affairs Canada claims these exports are only for non-lethal equipment.
  • Canada’s delayed and inconsistent response to Israel’s military violence in Gaza represents a failure to evenly apply its own foreign policy.
  • If Canada truly wants to create a more peaceful and prosperous world, they must not leave Palestinian women behind.


Jacqueline Potvin previously received funding from Social Sciences and Humanities Research Council. Mayme Lefurgey does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

WTA Foundation and Gates Foundation launch new campaign—Women Change the Game—to urge action on women’s health and nutrition

Retrieved on: 
Venerdì, Marzo 8, 2024
International, Woman, WTA, Dream, Quality of life, Wasting, Tennis, Global health, Government, Food, Life, Risk, Breast, Health, Face, Nutrient, WTA Tour, Stillbirth, Fund, Infant, UNICEF, Child, Movement, Bill, Workforce, Athlete, Mortality, Malnutrition, Partnership, Dietary supplement

A key component of the campaign is the first-of-its-kind WTA Foundation Global Women’s Health Fund.

Key Points: 
  • A key component of the campaign is the first-of-its-kind WTA Foundation Global Women’s Health Fund.
  • “It is unacceptable that so many women and girls don’t have access to adequate nutrition and basic care,” said Melinda French Gates, co-chair of the Bill & Melinda Gates Foundation.
  • “The WTA Foundation was founded on the idea of equal opportunity, and that’s exactly what Women Change the Game is about.
  • For more information about Women Change the Game and the WTA Foundation’s Global Women’s Health Fund, visit www.womenchangethegame.com .

QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada

Retrieved on: 
Mercoledì, Marzo 6, 2024
Data Management, Biotechnology, Baby, Maternity, Technology, Other Health, Health, Women, Health Technology, Medical Devices, Consumer, Clinical Trials, Pre-eclampsia, Eclampsia, Woman, Transfusion medicine, QuidelOrtho, Health Canada, Quality, Premature, Pregnancy, Risk, Diagnosis, Quality control, Safety, Prognosis, Biomarker, Lancet, Triage, Stillbirth, Guideline, HELLP, Placenta, Plasma, HELLP syndrome, Placentation, Medical device

QuidelOrtho Corporation (Nasdaq:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has received approval from Health Canada for its Triage PLGF test for laboratory use in Canada.

Key Points: 
  • QuidelOrtho Corporation (Nasdaq:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has received approval from Health Canada for its Triage PLGF test for laboratory use in Canada.
  • The Triage PLGF test is a fluorescence immunoassay to be used with the small footprint Triage MeterPro® Instrument for the quantitative determination of placental growth factor (“PLGF”) in maternal plasma specimens.
  • With the Triage PLGF test, clinicians can be positioned to better detect angiogenic imbalance and assess the risk for these complications.
  • The Triage PLGF test is available to customers in Canada for use with the Triage MeterPro instrument.

MG Foods Voluntarily Recalls Ham & Cotija Torta Sandwich Distributed in Florida Due to Possible Listeria Monocytogenes Contamination of Cotija Cheese

Retrieved on: 
Martedì, Febbraio 13, 2024
FDA, Retail, Health, Food, Beverage, Headache, Multimedia, Pregnancy, Diarrhea, Disease, Nausea, UPC, Stillbirth, Cheese, Listeria monocytogenes, Packaging and labeling, Abdominal pain, Dietary supplement

MG Foods is voluntarily recalling a Ham & Cotija Torta Sandwich on Telera Roll sold in Florida.

Key Points: 
  • MG Foods is voluntarily recalling a Ham & Cotija Torta Sandwich on Telera Roll sold in Florida.
  • This voluntary recall is being initiated as a result of the Rizo-López Foods, Inc. recall of cotija cheese due to possible contamination with Listeria monocytogenes and associated with an outbreak the FDA is currently investigating.
  • View the full release here: https://www.businesswire.com/news/home/20240213704482/en/
    MG Foods is voluntarily recalling a Ham & Cotija Torta Sandwich on Telera Roll sold in Florida.
  • This voluntary recall is being initiated as a result of the Rizo-López Foods, Inc. recall of cotija cheese due to possible contamination with Listeria monocytogenes and associated with an outbreak the FDA is currently investigating.

Giving birth in Sweden: outcomes are worse for foreign-born mothers

Retrieved on: 
Lunedì, Febbraio 12, 2024
Woman, Research, Infection, Language, Pregnancy, Communication, Stillbirth, Mother, COVID, Map, Child, Preterm birth, Mortality, Birth control

Unfortunately, these achievements don’t extend to foreign-born mothers who face higher risks for all forms of negative pregnancy outcomes.

Key Points: 
  • Unfortunately, these achievements don’t extend to foreign-born mothers who face higher risks for all forms of negative pregnancy outcomes.
  • Foreign-born mothers reported higher rates of infection, intensive care admission, preterm birth, underweight babies and stillbirths compared with Swedish-born mothers.
  • The evidence-based guidelines used in the Swedish healthcare system are backed by several high-quality registers that document patient outcomes at the population level.
  • Of the few variables collected, country of birth is one and job status is the other.
  • This means that the most valuable tool available to maternal healthcare professionals is essentially impaired from identifying how health inequities can affect birth outcomes.

Language barriers

  • Communication barriers due to a lack of proficiency in the Swedish language in foreign-born mothers is a large challenge in this regard.
  • In high-risk situations, like during an emergency caesarean section, such communication barriers may be critical and can even cost lives.
  • Also, there is limited understanding of how these language barriers affect foreign-born mothers’ overall understanding of the care they are receiving and their experiences of the quality of care provided.


Mehreen Zaigham receives funding from the Swedish Research Council Grant 2022–00208.

Fresh & Ready Foods Voluntarily Recalls Four Torta Sandwiches Containing Cotija Cheese Distributed in Arizona, California, Nevada, and Utah Due to Possible Listeria Monocytogenes Contamination

Retrieved on: 
Venerdì, Febbraio 9, 2024
Food, Beverage, Retail, Cheese, Listeria monocytogenes, Multimedia, Nausea, Abdominal pain, Stillbirth, Diarrhea, Pregnancy, Headache, FDA

Fresh & Ready Foods is voluntarily recalling four torta sandwiches that contain cotija cheese which were sold in Arizona, California, Nevada, and Utah.

Key Points: 
  • Fresh & Ready Foods is voluntarily recalling four torta sandwiches that contain cotija cheese which were sold in Arizona, California, Nevada, and Utah.
  • This voluntary recall is being initiated as a result of the Rizo-López Foods, Inc. recall of cotija cheese due to possible contamination with Listeria monocytogenes and associated with an outbreak the FDA is currently investigating .
  • View the full release here: https://www.businesswire.com/news/home/20240209222087/en/
    Fresh & Ready Foods is voluntarily recalling four torta sandwiches that contain cotija cheese which were sold in Arizona, California, Nevada, and Utah.
  • The recalled products were distributed between 01/21/2024 and 02/06/2024 and sold exclusively in locations in Arizona, California, Nevada, and Utah.

FSIS Public Health Alert - Listeria monocytogenes

Retrieved on: 
Venerdì, Febbraio 9, 2024
USDA, Office for Civil Rights, RTE, Diarrhea, Food safety, Pregnancy, FDA, Food, Cheese, Meat, Human, Gastrointestinal tract, Fever, Stillbirth, CHICKEN, Headache, Quality assurance, Poultry, Civil and political rights, Myalgia, Eating, Listeriosis, Independence Avenue, Person, BLACK, Infection, Listeria monocytogenes, Food and Drug Administration, Confusion, BEST, FSIS, TDD, Dietary supplement

FSIS is issuing this public health alert to ensure that consumers are aware that these products, which bear the USDA mark of inspection, should not be consumed.

Key Points: 
  • FSIS is issuing this public health alert to ensure that consumers are aware that these products, which bear the USDA mark of inspection, should not be consumed.
  • As more information becomes available, FSIS will update this public health alert.
  • The following products subject to the public health alert are [ view labels ]:
    10.53-oz.
  • The problem was discovered when the firm notified FSIS that they used FDA-regulated cotija cheese that may be contaminated with Listeria monocytogenes to produce burrito products.